In 1Q16, LabCorp’s (LH) national clinical laboratory business, LabCorp Diagnostics, accounted for 69.3% of the company’s total revenues. Despite facing the impact of about -0.6% in revenues on a ...
Hosted on MSN
LH Q3 Deep Dive: Labcorp Sees Diagnostic Growth, Eyes Specialty Testing and Efficiency Initiatives
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share was 1% above analysts’ consensus ...
Earnings Call Insights: Labcorp Holdings Inc. (NYSE:LH) Q4 2024 Labcorp reported revenue of $3.3 billion for Q4 2024, an increase of 10% year-over-year, with Diagnostics and Biopharma segments each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback